Skip to main content
ImmuneCited

Descrizione

Characteristics of included clinical trials evaluating EPs 7630 for acute bronchitis and tonsillopharyngitis in children are summarized.

Cite This Figure

![Figure 2: Characteristics of included clinical trials evaluating EPs 7630 for acute bronchitis and tonsillopharyngitis in children are summarized.]()

> Source: Georg Seifert et al. "Faster recovery and reduced paracetamol use - a meta-analysis of EPs 7630 in chi." *BMC pediatrics*, 2019. PMID: [31014293](https://pubmed.ncbi.nlm.nih.gov/31014293/)
<figure>
  <img src="" alt="Characteristics of included clinical trials evaluating EPs 7630 for acute bronchitis and tonsillopharyngitis in children are summarized." />
  <figcaption>Figure 2. Characteristics of included clinical trials evaluating EPs 7630 for acute bronchitis and tonsillopharyngitis in children are summarized.<br>  Source: Georg Seifert et al. "Faster recovery and reduced paracetamol use - a meta-analysis of EPs 7630 in chi." <em>BMC pediatrics</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31014293/">31014293</a></figcaption>
</figure>